About Angion
We are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Our goal is to transform the treatment paradigm for patients suffering from these potentially life-threatening conditions for which there are no approved medicines or where existing approved medicines have limitations.
|
|
|
1-10 employees
View all Angion employees
|
|
Biotechnology
|
|
$10M–$50M
|
|
(212) 555-1234
|
|
51 Charles Lindbergh Blvd, Uniondale, New York 11553, US
|
|
None
|
Angion Alternatives
Frequently Asked Questions about Angion
The decision makers in Angion are Anthony Angion, Bert Oehlen, David Upchurch, etc. Click to Find Angion decision makers emails.
Angion headquarters is located at 51 Charles Lindbergh Blvd, Uniondale, New York 11553, US.
Angion generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Angion by calling (212) 555-1234.
Angion Staff Directory
Search Angion Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
